| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_TMEM165_0000700 | Intron-Exon-Intron | chr4:56265253-56278006 | chr4:55399086-55411839 | 226 nt | 0.4204 |
| hsa_TMEM165_0000800 | Intron-Exon-Intron | chr4:56265253-56284152 | chr4:55399086-55417985 | 286 nt | 0.3846 |
| hsa_TMEM165_0000900 | Intron-Exon | chr4:56265253-56291655 | chr4:55399086-55425488 | 113 nt | 0.3274 |
| hsa_TMEM165_0001000 | Intron-Exon-Intron | chr4:56265267-56269505 | chr4:55399100-55403338 | 250 nt | 0.3040 |
| hsa_TMEM165_0001200 | Intron-Exon-Intron | chr4:56265267-56284152 | chr4:55399100-55417985 | 337 nt | 0.3976 |
| hsa_TMEM165_0001100 | Intron-Exon-Intron | chr4:56265267-56284331 | chr4:55399100-55418164 | 250 nt | 0.3400 |
| hsa_TMEM165_0001300 | Intron-Intron | chr4:56265277-56265420 | chr4:55399110-55399253 | 144 nt | 0.4167 |
| hsa_TMEM165_0001400 | Intron-Exon-Intron | chr4:56265913-56269505 | chr4:55399746-55403338 | 250 nt | 0.3640 |
| hsa_chr4_0486300 | Intergenic-Intergenic | chr4:56266892-56267287 | chr4:55400725-55401120 | 396 nt | 0.3611 |
| hsa_TMEM165_0001500 | Intron-Exon-Intron | chr4:56267820-56269505 | chr4:55401653-55403338 | 1686 nt | 0.4187 |
A study in humans demonstrated that the circTMEM165 (hsa_circ_0001414) was significantly upregulated in the peripheral blood of myocardial infarction patients compared to healthy controls, as identified by RNA sequencing and validated by RT-qPCR [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in human patients with ST-segment elevation myocardial infarction (STEMI) identified the circTMEM165 as a differentially expressed circular RNA in peripheral blood, a finding that was confirmed in an AC16 cell model [Wang et al. DOI:10.1515/med-2023-0807].